报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 7.63% | 13.04% | 46.17% | 42/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 5.22% | 6.1% | 97.73% | 36/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 2.64% | -1.49% | -67.61% | 45/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 8.15% | -39.41% | 20.74% | 40/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 6.75% | -37.67% | 37.2% | 48/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 4.92% | -33.87% | 83.58% | 43/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 2.68% | -13.83% | -80.07% | 45/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 13.45% | -8.44% | 24.19% | 25/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 10.83% | -14.32% | 45.56% | 28/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 7.44% | -31.24% | 139.23% | 24/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 3.11% | -42.51% | -78.83% | 35/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 14.69% | -45.81% | 16.22% | 21/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 12.64% | 2% | 16.82% | 17/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 10.82% | -31.3% | 100% | 12/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 5.41% | 2% | -80.04% | 9/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 27.11% | 57.98% | 72.13% | 8/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-06-30 | 15.75% | 2% | -8.22% | 7/160 | 4.24% | 汇宇制药 | 55.94% | 行业排名> |
2019-12-31 | 17.16% | 2% | 2% | 25/160 | 2.78% | 河化股份 | 45.32% | 行业排名> |